Cargando…
Novel drug candidate for the treatment of several soft-tissue sarcoma histologic subtypes: A computational method using survival-associated gene signatures for drug repurposing
Systemic treatment options for soft tissue sarcomas (STSs) have remained unchanged despite the need for novel drug candidates to improve STS outcomes. Drug repurposing involves the application of clinical drugs to different diseases, reducing development time, and cost. It has also become a fast and...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412453/ https://www.ncbi.nlm.nih.gov/pubmed/30816547 http://dx.doi.org/10.3892/or.2019.7033 |